• Weidong Lu, Mary Jane Ott, Stacy Kennedy, Maria B Mathay, Anne M Doherty-Gilman, Elizabeth Dean-Clower, Carolyn M Hayes, and David S Rosenthal.
• Dana-Farber Cancer Institute, Boston, MA 02115, USA.
• Integr Cancer Ther. 2009 Sep 1; 8 (3): 235-41.

AbstractA 34-year-old woman carrying a BRCA1 gene and a significant family history was diagnosed with T1c, N1 breast cancer. The tumor was estrogen receptor, progesterone receptor, and HER-2/Neu negative. The patient received dose-dense chemotherapy with Adriamycin and Cytoxan followed by Taxol, and left breast irradiation. Later, a bilateral S-GAP flap reconstruction with right prophylactic mastectomy and left mastectomy were performed. During her treatment, the patient had an integrative medicine consultation and was seen by a team of health care providers specializing in integrative therapies, including integrative nutrition, therapeutic massage, acupuncture, and yoga. Each modality contributed unique benefit in her care that led to a satisfactory outcome for the patient. A detailed discussion regarding her care from each modality is presented. The case elucidates the need for integrative approaches for cancer patients in a conventional medical setting.

27 keywords...

hide…